We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Examine: 15.4% of 0- to 35-month-olds obtain invalid vaccine dose
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Examine: 15.4% of 0- to 35-month-olds obtain invalid vaccine dose
Examine: 15.4% of 0- to 35-month-olds obtain invalid vaccine dose
Health

Examine: 15.4% of 0- to 35-month-olds obtain invalid vaccine dose

Last updated: January 11, 2025 1:58 am
Editorial Board Published January 11, 2025
Share
SHARE

Total, 15.4% of youngsters aged 0 to 35 months obtain an invalid vaccine dose, receiving a vaccine earlier or later than beneficial, in keeping with a research printed on-line Jan. 10 in Pediatrics.

Alexandria N. Albers, M.P.H., from the College of Montana in Missoula, and colleagues analyzed provider-verified vaccination data from the 2011 to 2020 Nationwide Immunization Survey-Little one to quantify the prevalence of invalid doses amongst U.S. kids aged 0 to 35 months. Invalid doses are these supplied outdoors the Advisory Committee on Immunization Practices for minimal and most ages of vaccination and minimal intervals between doses.

The researchers discovered that 22,209 of 161,187 kids (weighted %, 15.4%) had an invalid vaccine dose. Total, 44.9% of youngsters with a minimal age or minimal interval invalid dose acquired further doses and accomplished the collection. The best prevalence of invalid doses was seen for the three-dose rotavirus (4.4%), with 3.1% having the primary dose administered after the utmost age. From 2011 to 2020, there was a lower seen within the share of youngsters with an invalid dose (16.9 to 12.5%). The chances of an invalid dose had been larger for youngsters who moved throughout state strains versus those that didn’t (adjusted odds ratio, 1.5).

“To reduce invalid vaccine administration overall, equity-based national and state investments in immunization information systems and clinical support tools that help providers make accurate recommendations are needed in all settings where children receive vaccinations,” the authors write.

Extra data:
Alexandria N. Albers et al, Invalid Vaccine Doses Amongst Kids Aged 0 to 35 Months: 2011 to 2020, Pediatrics (2025). DOI: 10.1542/peds.2024-068341

David G Bundy, Vaccination Timing: Threading the Needle Between “Too Early” and “Too Late”, Pediatrics (2025). DOI: 10.1542/peds.2024-068972

© 2025 HealthDay. All rights reserved.

Quotation:
Examine: 15.4% of 0- to 35-month-olds obtain invalid vaccine dose (2025, January 10)
retrieved 10 January 2025
from https://medicalxpress.com/information/2025-01-month-olds-invalid-vaccine-dose.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

Early prediction of preterm start in cell-free RNA may reshape prevention methods

Extra will be executed to stop widespread sort of stroke, say consultants

Novel immune cell inhabitants might supply various goal for tuberculosis vaccines

Hay fever: Why signs are so unhealthy this 12 months, and what to do in case your common treatments aren’t working

Swept-source anterior section optical coherence tomography can assist distinguish early childhood glaucoma

TAGGED:35montholdsdoseinvalidReceivestudyvaccine
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
The  Billion database wager: What Databricks’ Neon acquisition means on your AI technique
Technology

The $1 Billion database wager: What Databricks’ Neon acquisition means on your AI technique

Editorial Board May 16, 2025
Sam Bankman-Fried, Crypto Billionaire, Wants Washington to Follow His Lead
Max Scherzer Finishes Rehab Stint and Is Set to Rejoin Mets
Book Review: ‘The Nineties,’ by Chuck Klosterman
Examine: One-week breast most cancers radiotherapy confirmed as secure and efficient as normal three-week therapy

You Might Also Like

Hundreds of thousands of HealthCare.gov contributors face protection loss on account of burdensome reenrollment insurance policies
Health

Hundreds of thousands of HealthCare.gov contributors face protection loss on account of burdensome reenrollment insurance policies

May 24, 2025
US extra deaths proceed to rise even after the COVID-19 pandemic, research finds
Health

US extra deaths proceed to rise even after the COVID-19 pandemic, research finds

May 24, 2025
Organ-specific irritation masquerades as relapse in CAR T-cell remission
Health

Organ-specific irritation masquerades as relapse in CAR T-cell remission

May 24, 2025
Novel lengthy noncoding RNA could function therapeutic goal for prostate most cancers
Health

Novel lengthy noncoding RNA could function therapeutic goal for prostate most cancers

May 24, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?